To further verify the contrast agent targeted to the HER2 positive tumor, we carried out immunohistochemistry (IHC) staining using the antibody PAbPGCA1 with tissue slides made from the tumor samples collected from the imaged mice as well as selected organs. This evidence concerns the gene ERBB2 and neoplasm.